Future Oncology, Volume 19, Issue 32 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Future Oncology, Volume 19, Issue 32 (2023)

See all volumes and issues
Vol 20, 2024 Volume 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Clinical Trial Protocol

Review Article
Randomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancer
Tadayoshi Hashimoto, Izuma Nakayama, Manabu Ohashi, Junki Mizusawa, Hiroshi Kawachi, Ryosuke Kita, Haruhiko Fukuda, Yukinori Kurokawa, Narikazu Boku, Takaki Yoshikawa & Masanori Terashima
Pages: 2147-2155
Published online: 26 Oct 2023
AbstractforRandomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancer | Full Text | References | PDF (1.4 MB) | EPUB
  • 80 Views
  • 0 CrossRef citations
  • 0Altmetric

Preliminary Communication

Brief Report
Analysis of the risk factors of radiation pneumonitis and the predictive ability of dosiomics in non-small-cell lung cancer
Lei Zhuang, Xue Bai, Ying Chen, Danhong Zhang, Liming Sheng & Xianghui Du
Pages: 2157-2169
Published online: 27 Oct 2023
AbstractforAnalysis of the risk factors of radiation pneumonitis and the predictive ability of dosiomics in non-small-cell lung cancer | Full Text | References | PDF (1.8 MB) | EPUB
  • 81 Views
  • 0 CrossRef citations
  • 0Altmetric

Short Communication

Brief Report
Response heterogeneity as a new biomarker of treatment response in patients with neuroendocrine tumors
Clarisse Dromain, Marianne Pavel, Maxime Ronot, Niklaus Schaefer, Dalvinder Mandair, Delphine Gueguen, Catherine Cheng, Olivier Dehaene, Kathryn Schutte, David Cahané, Simon Jégou & Félix Balazard
Pages: 2171-2183
Published online: 27 Jul 2023
AbstractforResponse heterogeneity as a new biomarker of treatment response in patients with neuroendocrine tumors | Full Text | References | PDF (2.1 MB) | EPUB
  • 1104 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Research Article

Article
The use of deep learning models to predict progression-free survival in patients with neuroendocrine tumors
Marianne Pavel, Clarisse Dromain, Maxime Ronot, Niklaus Schaefer, Dalvinder Mandair, Delphine Gueguen, David Elvira, Simon Jégou, Félix Balazard, Olivier Dehaene & Kathryn Schutte
Pages: 2185-2199
Published online: 27 Jul 2023
AbstractforThe use of deep learning models to predict progression-free survival in patients with neuroendocrine tumors | Full Text | References | PDF (3.1 MB) | EPUB
  • 1161 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Meta-Analysis

Article
Meta-analysis of quality of life in patients with cancer treated with antibody-drug conjugates in randomized controlled trials
Tianlei Qiu, Guoshuang Shen, Yuanfang Xin, Jinming Li, Yonghui Zheng, Zijun Zhu, Chengrong Zhang, Yuyao Tang, Miaozhou Wang, Zhen Liu, Yi Zhao, Fuxing Zhao, Dengfeng Ren, Huihui Li, Yaobang Liu, Xinlan Liu & Jiuda Zhao
Pages: 2201-2212
Published online: 26 Oct 2023
AbstractforMeta-analysis of quality of life in patients with cancer treated with antibody-drug conjugates in randomized controlled trials | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 73 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer
Anwaar Saeed et al.
Method | Published online: 23 Jul 2024
Gastric cancer in pregnancy: a review
Hongming Liu et al.
Review Article | Published online: 23 Jul 2024
A novel prognostic index for extranodal natural killer/T-cell lymphoma in the era of pegaspargase/L-asparaginase
Ziyuan Shen et al.
Article | Published online: 23 Jul 2024
An investigator-initiated clinical study in patients with refractory or recurrent solid tumors: ‘R-ISV-FOLactis’ trial
Juanjuan Dai et al.
Method | Published online: 21 Jul 2024
View all latest articles